Search

everythinglearnresearchcommunity

for

Search:↓

Women with irregular periods have a higher risk of heart disease.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Lower testosterone levels may increase heart failure risk in older men.

Hair loss may increase heart disease risk.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Androgenetic alopecia is linked to a higher risk of coronary heart disease due to certain genetic factors and high homocysteine levels.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Anabolic steroids harm the heart, liver, hormones, muscles, and mental health.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Young women with PCOS and no other heart risk factors have normal heart function.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Hair loss may indicate higher heart risk and metabolic issues.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Using steroids can increase the risk of heart problems.

People with vitiligo may have a lower risk of heart disease.